Back to Search Start Over

Disentangling the relationship of subjective cognitive decline and depressive symptoms in the development of cognitive decline and dementia.

Authors :
Kleineidam L
Wagner M
Guski J
Wolfsgruber S
Miebach L
Bickel H
König HH
Weyerer S
Lühmann D
Kaduszkiewicz H
Luppa M
Röhr S
Pentzek M
Wiese B
Maier W
Scherer M
Kornhuber J
Peters O
Frölich L
Wiltfang J
Lewczuk P
Hüll M
Ramirez A
Jessen F
Riedel-Heller SG
Heser K
Source :
Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2023 May; Vol. 19 (5), pp. 2056-2068. Date of Electronic Publication: 2022 Oct 11.
Publication Year :
2023

Abstract

Introduction: Subjective cognitive decline (SCD) and depressive symptoms (DS) frequently co-occur prior to dementia. However, the temporal sequence of their emergence and their combined prognostic value for cognitive decline and dementia is unclear.<br />Methods: Temporal relationships of SCD, DS and memory decline were examined by latent difference score modeling in a high-aged, population-based cohort (N = 3217) and validated using Cox-regression of dementia-conversion. In 334 cognitively unimpaired SCD-patients from memory-clinics, we examined the association of DS with cognitive decline and with cerebrospinal fluid (CSF) Alzheimer's disease (AD) biomarkers.<br />Results: In the population-based cohort, SCD preceded DS. High DS were associated with increased risk of dementia conversion in individuals with SCD. In SCD-patients from memory-clinics, high DS were associated with greater cognitive decline. CSF Aß42 predicted increasing DS.<br />Discussion: SCD typically precedes DS in the evolution to dementia. SCD-patients from memory-clinics with DS may constitute a high-risk group for cognitive decline.<br />Highlights: Subjective cognitive decline (SCD) precedes depressive symptoms (DS) as memory declines. Emerging or persistent DS after SCD reports predict dementia. In SCD patients, more amyloid pathology relates to increasing DS. SCD patients with DS are at high risk for symptomatic progression.<br /> (© 2022 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.)

Details

Language :
English
ISSN :
1552-5279
Volume :
19
Issue :
5
Database :
MEDLINE
Journal :
Alzheimer's & dementia : the journal of the Alzheimer's Association
Publication Type :
Academic Journal
Accession number :
36218120
Full Text :
https://doi.org/10.1002/alz.12785